FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1304324002: Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5310146019 Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5310147011 Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Is a Efavirenz and emtricitabine and tenofovir only product in oral dose form true Inferred relationship Some
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antiretroviral therapeutic role false Inferred relationship Some
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Efavirenz (substance) true Inferred relationship Some 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Efavirenz (substance) true Inferred relationship Some 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Emtricitabine (substance) true Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Emtricitabine (substance) true Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Tenofovir disoproxil succinate (substance) true Inferred relationship Some 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Tenofovir disoproxil (substance) true Inferred relationship Some 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start